Mereo BioPharma Group plc (MREO) › Weighted Average Diluted SharesMereo BioPharma Group plc (MREO) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2022-12-31: 603.20M2023-12-31: 659.45M2024-12-31: 739.62M2025-12-31: 797.12M797.12M2022-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31797.12M+7.8%2026-03-19From 2025-01-012024-12-31739.62M+12.2%2026-03-19From 2024-01-012023-12-31659.45M+9.3%2025-03-26From 2023-01-012022-12-31603.20M—2024-03-27From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)